Upcoming IPO: Fintech unicorn Moneyview files draft papers with Sebi

by Hansraj Agrawal | Mar 4, 2026 | Share Market

Moneyview IPO: Credit-led fintech platform Moneyview has filed its draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (Sebi), moving a step closer to its proposed initial public offering (IPO).

According to the DRHP, the Bengaluru-headquartered company’s IPO comprises a fresh issue of equity shares aggregating up to ₹1,500 crore, and an offer for sale (OFS) of up to 13.6 crore equity shares by existing shareholders.

The promoter selling shareholders include Puneet Agarwal and Sanjay Aggarwal, while the promoter group selling shareholder is Chitra Agarwal. Investor selling shareholders participating in the OFS are Internet Fund III Pte. Ltd., Accel India IV (Mauritius) Limited, Accel Growth IV Holdings (Mauritius) Ltd., Crimson Winter Limited, Lok Capital IV LLC, Lok Capital Co-investment Trust, Ribbit Capital, Evolvence India Fund IV Limited, Apis Growth II (Mimosa) Pte. Ltd., NLI Strategic Venture Investment Limited, TI JPNIN India Holdco Ltd., TI Platform SMRS SMA, L.P., and DI Investment LLC.

The company will not receive any proceeds from the OFS. “Each of the Selling Shareholders shall be entitled to its respective portion of the proceeds of the Offer for Sale after deducting its proportion of the Offer expenses and relevant taxes thereon, as applicable. Our Company will not receive any proceeds from the Offer for Sale and the proceeds received from the Offer for Sale will not form part of the Net Proceeds,” the company said in its DRHP.

Moneyview proposes to utilise the net proceeds from the fresh issue to fund growth in its financial services business. This includes ₹650 crore towards driving loan disbursals under Default Loss Guarantee (DLG) arrangements, ₹450 crore for investment in its material subsidiary, Whizdm Finance Private Limited (WFPL), to augment its capital base, and the remaining amount for general corporate purposes.

Axis Capital, BofA Securities India, IIFL Capital Services, and Kotak Mahindra Capital Company are the book running lead managers to the issue.

The company proposes to list its equity shares on the BSE and NSE.

About Moneyview

Founded in 2014 by IIT Delhi graduates Puneet Agarwal, Managing Director and Chief Executive Officer, and Sanjay Aggarwal, Executive Director and Chief Technology Officer, Moneyview is backed by investors such as Accel, Tiger Global, and Ribbit Capital, among others.

The Moneyview app offers financial products across four categories: Borrow, Transact, Invest, and Protect, enabling users to access multiple services on a single platform. Its flagship product, digital personal loans, was launched in 2017 and continues to be a key revenue driver. As of December 31, 2025, the company reported managed assets under management of ₹19,814 crore.

Source link

Infosys rises on pact to deepen collaboration with Intel to accelerate enterprise-scale AI deployment

by Hansraj Agrawal | Mar 4, 2026 | Share Market

Infosys added 1.06% to Rs 1301.85 after the company announced the next phase of strategic collaboration with Intel to help enterprises transition AI initiatives from pilot stages to scaled production deployments.

The partnership integrates Infosys Topaz Fabric, the companys agentic AI services suite, with Intels high-performance compute stack, including Intel Xeon processors, Intel Gaudi AI accelerators, and Intel AI PCs.

The partnership integrates Intels high-performance, energy-efficient compute platforms with Infosys Topaz Fabric, the companys purpose-built AI services suite designed to unify infrastructure, models, data, and workflows into an enterprise-ready AI ecosystem.

The collaboration focuses on co-designing and optimizing AI workloads across Intel Xeon processors, Intel Gaudi AI accelerators, and Intel AI PCs.

The companies are targeting right-sizedAI architectures that balance performance, security, and total cost of ownership, with particular emphasis on mission-critical enterprise use cases such as IT operations, developer productivity, and automation workflows.

By combining hardware-level optimization with platform-led services integration, Infosys stated that it intends to positioning itself deeper in clients AI infrastructure stack, potentially strengthening long-term deal stickiness and improving revenue visibility in AI-led transformation programs.

Salil Parekh, chief executive officer, Infosys, said: Our collaboration with Intel reflects Infosys commitment to embedding AI deeply and responsibly across enterprise operations.

By bringing together Intels compute leadership and the capabilities of Infosys Topaz, we are enabling enterprises to unlock AI value at scale securely, cost-effectively, and with clear business impact.

Infosys is a global leader in next-generation digital services and consulting.

The company reported a 9.6% decline in consolidated net profit to Rs 6,654 crore on a 2.22% increase in revenue from operations to Rs 45,479 crore in Q3 FY26 over Q2 FY26.

Powered by Capital Market – Live News

Source link

Cartrade Tech launches AI-powered transaction tool – SuperDost

by Hansraj Agrawal | Mar 4, 2026 | Share Market

Last Updated : Mar 04 2026 | 12:16 PM IST

Cartrade Tech announced the launch of SuperDost: an AI-powered transaction tool designed to power instant transactions between high-intent buyers and sellers for Automobiles and Used Products.

SuperDost is a live AI Agent which operationalizes the ‘Matchmaker’ strategy by leveraging the combined scale and proprietary data of over 85 million unique monthly visitors across OLX India and CarWale to drive
real-time and Instant, high-intent transactions between buyers and sellers for Automobiles and Used Products.

SuperDost is designed for instant, intelligent matchmaking at scale, bringing together the Company’s Consumers, Dealers and Partners across Automobiles and Used Products within a unified AI-powered interface. It Real-Time connects the most relevant, high-intent buyers and sellers across the platforms.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 04 2026 | 12:16 PM IST

Source link

Silver Touch Technologies secures project from CIMR, New Delhi

by Hansraj Agrawal | Mar 4, 2026 | Share Market

Last Updated : Mar 04 2026 | 11:16 AM IST

To design and develop website and digital platform

Silver Touch Technologies has been awarded the project for designing and development of the website and digital platform for the Centre for Integrative Medicine & Research (CIMR), AIIMS New Delhi.

CIMR is envisioned as a premier national centre dedicated to the convergence of contemporary medicine with Indias traditional systems of healthcare, fostering interdisciplinary research, clinical integration, and evidence-based integrative medical practices.

The digital platform will enable:
h – Structured dissemination of research outcomes
h – Transparent publication of clinical studies and data
h – Seamless stakeholder engagement (researchers, clinicians, students, policymakers)
h – Secure digital governance of medical knowledge assets

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Mar 04 2026 | 11:16 AM IST

Source link

Natco Pharma shares rise 3% in weak mkt on launching generic Pomalyst in US

by Hansraj Agrawal | Mar 4, 2026 | Share Market

Natco Pharma shares rose 3.5 per cent in trade on the BSE, logging an intra-day high at ₹990 per share. At 9:55 AM, Natco Pharma’s share price was trading 2.86 per cent higher at ₹983.8. In comparison, Nifty was down 2.02 per cent at 78,616.07.

The buying on the counter came after the company, along with Breckenridge Pharmaceutical, launched Pomalidomide Capsules, a generic version of Pomalyst by Celgene, in the US market.

In an exchange filing, Natco said the product is indicated for adult patients with multiple myeloma who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor, and have shown disease progression during or within 60 days of the last treatment. The drug is also approved for AIDS-related Kaposi sarcoma after failure of highly active antiretroviral therapy, and for HIV-negative adult patients with Kaposi sarcoma.

The company said pomalidomide capsules will be available in 1 mg, 2 mg, 3 mg and 4 mg strengths and will be distributed primarily through specialty pharmacies and clinics.

Natco said the reference product had estimated US sales of $3.2 billion for the 12 months ended September 2025, citing industry sales data. The company also said it believes, based on information made available by the US Food and Drug Administration (FDA), that it has 180 days of shared exclusivity.

“We are pleased to launch Pomalidomide Capsules in the U.S.; this further strengthens our oncology and specialty portfolio in the U.S.,” said Rajeev Nannapaneni, Vice Chairman and CEO of Natco Pharma, according to the release.

Breckenridge said it is supporting the launch with copay assistance for eligible patients to help reduce treatment delays and maintain continuity of care.

That apart, in Q3FY26, Natco Pharma reported a net profit of ₹151.3 crore, as compared to ₹132.4 crore. Its revenue from operations stood at ₹705.4 crore as compared to ₹651.1 crore year-on-year (Y-o-Y).

Natco Pharma, headquartered at Hyderabad, India, develops, manufactures, and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients, and crop protection products. The company is research and development (R&D) oriented, and a science-driven, leading Oncology player in the targeted therapies of the domestic market, and focuses on limited competition molecules in the US.

Source link

L&T, KEC, Apar: How West Asia conflict could hit these capital goods firms?

by Hansraj Agrawal | Mar 4, 2026 | Share Market

Escalating geopolitical tensions between the United States (US) and Iran are adding to global macro uncertainty, with renewed concerns that disruption through the Strait of Hormuz could support crude oil prices and increase market volatility, believes PL Capital. While higher oil prices can strengthen fiscal balances and liquidity for hydrocarbon-driven Gulf economies, prolonged instability could also weigh on project execution through higher freight and insurance costs, supply-chain bottlenecks, and potential deferral of private capital expenditure, noted analysts.

For Indian corporates, according to the report, the risks are most relevant for companies with meaningful exposure to the West Asia across engineering, procurement, and construction (EPC), oil & gas services, power transmission, defence exports and infrastructure, where near-term performance could swing based on project concentration by country, contract structures, receivable cycles, and on-ground execution constraints.

PL Capital reckons India’s West Asia-exposed companies may face near-term headwinds such as execution disruptions, logistics challenges, slower tender finalisations, deferment of new orders, and postponement of dispatches as customers reassess project timelines. The brokerage said the impact remains company-specific and will become clearer as management teams provide updates.

L&T:

Larsen & Toubro (L&T) stands out with a heavy international mix, with around 75 per cent of its overseas order book linked to West Asia, spanning hydrocarbons, oil & gas EPC, power transmission and distribution, and water projects across Saudi Arabia, the UAE, and Qatar. Any further escalation could affect both incremental order inflows and execution schedules, analysts said.

KEC International:

KEC International has Middle East exposure of roughly 20 per cent (around ₹10,000 crore order book), according to estimates. Analysts noted that revenue from its UAE factory—around ₹60 crore per month—could be at risk, though operations in Saudi Arabia and other regions are continuing normally, limiting the near-term financial impact unless disruptions extend.

Kalpataru Projects:

Kalpataru Projects has exposure across oil & gas and power trasmission and distribution (T&D). The company had indicated it was qualified for five large West Asia projects (as per Q3 commentary), which could face delays in award timelines if uncertainty persists, analysts said.

Engineers India:

Engineers India (EIL) has consultancy assignments in Saudi Arabia, Oman, and Kuwait linked to overseas oil & gas projects. Analysts said regional tensions could lead to slower tender finalisation and delayed project awards, moderating consultancy inflows in the near term.

Apar Industries:

Apar Industries has about 5 per cent revenue exposure to West Asia and operates a manufacturing facility in the UAE with a subsidiary in Saudi Arabia. Analysts flagged risks from logistics disruptions, higher freight/insurance costs, and crude-linked raw material inflation, which could create near-term margin volatility.

Other names: Order timing and demand risks

Kirloskar Pneumatic has limited exposure (historically under 10 per cent) but is already seeing delays in oil & gas orders from West Asia, with the potential for further order and execution slippage if tensions intensify. Cummins India, which exports gensets and provides services in Middle East markets, could face short-term demand volatility as well as logistics and input cost pressures.

Further, PL Capital said it is monitoring company-specific exposures and awaiting further clarity from management commentary to assess the extent and duration of the impact if geopolitical stress remains elevated.

Disclaimer: Views and recommendations are those of the brokerage/analyst and are not endorsements. Readers should exercise discretion.

Source link

« Older Entries

Next Entries »

Times Top News

Times Top News

Recent Posts

Recent Comments